These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 267629)

  • 1. Influence of inhaled Ca-DTPA on the long-term effects of inhaled Pu nitrate.
    Ballou JE; Dagle GE; McDonald KE; Buschbom RL
    Health Phys; 1977 Jun; 32(6):479-87. PubMed ID: 267629
    [No Abstract]   [Full Text] [Related]  

  • 2. Plutonium: biomedical research.
    Bair WJ; Thompson RC
    Science; 1974 Feb; 183(4126):715-22. PubMed ID: 4595239
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates.
    Stather JW; Stradling GN; Gray SA; Moody J; Hodgson A
    Hum Toxicol; 1985 Nov; 4(6):573-82. PubMed ID: 4077069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic and therapeutic study following administration to rats of 238 Pu nitrate--a comparison with 239 Pu.
    Morin M; Nenot JC; Lafuma J
    Health Phys; 1972 Oct; 23(4):475-80. PubMed ID: 4634927
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of DTPA treatments following the injection of particulate plutonium.
    Bruenger FW; Taylor DM; Taylor GN; Lloyd RD
    Int J Radiat Biol; 1991 Nov; 60(5):803-18. PubMed ID: 1680951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose responses from inhaled monodisperse aerosols of 244Cm2O3 in the lung, liver and skeleton of F344 rats and comparison with 239PuO2.
    Lundgren DL; Hahn FF; Carlton WW; Griffith WC; Guilmette RA; Gillett NA
    Radiat Res; 1997 May; 147(5):598-612. PubMed ID: 9146706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium.
    Stather JW; Rodwell P
    Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032
    [No Abstract]   [Full Text] [Related]  

  • 9. 239 Pu: problems of its biological effect.
    Moskalev YI
    Health Phys; 1972 Jun; 22(6):723-9. PubMed ID: 4507894
    [No Abstract]   [Full Text] [Related]  

  • 10. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
    Grémy O; Coudert S; Renault D; Miccoli L
    Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone tumors induced by inhalation of 238PuO2 in dogs.
    Park JF; Lund JE; Ragan HA; Hackett PL; Frazier ME
    Recent Results Cancer Res; 1976; (54):17-35. PubMed ID: 1070720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of inhaled plutonium dioxide in beagle dogs.
    Muggenburg BA; Guilmette RA; Mewhinney JA; Gillett NA; Mauderly JL; Griffith WC; Diel JH; Scott BR; Hahn FF; Boecker BB
    Radiat Res; 1996 Mar; 145(3):361-81. PubMed ID: 8927705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
    Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
    Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior and biological action of large amounts of 239Pu following intramuscular administration in rats undergoing long-term therapy with Zn- and Ca-DTPA].
    Siniakov EG; Bazhin AG; Liubchanskiĭ ER; Nifatov AP
    Radiobiologiia; 1987; 27(1):129-30. PubMed ID: 3469686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 16. DTPA therapy for chelation of 239 Pu in bone: the influence of bone remodelling.
    James AC; Taylor DM
    Health Phys; 1971 Jul; 21(1):31-9. PubMed ID: 5114657
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary bone neoplasms in beagle dogs exposed by inhalation to aerosols of plutonium-238 dioxide.
    Hahn FF; Mewhinney JA; Merickel BS; Guilmette RA; Boecker BB; McClellan RO
    J Natl Cancer Inst; 1981 Oct; 67(4):917-27. PubMed ID: 6944558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 19. Early effects of inhaled Ca-DTPA on the rat lung.
    Smith VH; Dagle GE; Gelman RA; Ragan HA
    Toxicol Lett; 1980 Nov; 7(1):9-16. PubMed ID: 7292518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of human urinary excretion of plutonium for cases treated with DTPA.
    Jech JJ; Andersen BV; Heid KR
    Health Phys; 1972 Jun; 22(6):787-92. PubMed ID: 5084012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.